Important New Changes to Improve Access to Behavioral Health in Medicare
(Source – cms.gov/blog) As we emerge from the COVID-19 public health emergency, it is abundantly clear that our nation must
Read More(Source – cms.gov/blog) As we emerge from the COVID-19 public health emergency, it is abundantly clear that our nation must
Read MoreA recent study by the Kaiser Family Foundation found that 22 percent of people ages 65 and up said they
Read MoreThe FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read More(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage enrollment has grown rapidly in recent years, now enrolling over half of
Read More(By Chris Lee for The Kaiser Family Foundation published July 12, 2023) A new KFF analysis finds that the 10
Read More(Source – www.cms.gov/newsroom) The U.S. Department of Health and Human Services (HHS), announced actions to protect consumers from junk health
Read More(By Rylee Wilson for Becker’s Hospital Review) Leqembi, the newly-approved drug that can slow the progression of Alzhemier’s disease, will
Read More(Source – www.cms.gov/newsroom) For the first time in history, Medicare has the ability to directly negotiate the prices of covered
Read More(By Rylee Wilson for Becker’s Hospital Review) Medicare could have overpaid hundreds of millions for genetic testing from 2018 to
Read More(By Jon Hamilton for NPR) The first drug shown to slow down Alzheimer’s disease is likely to receive full approval
Read More